A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Noah Medical Reports New R & D Training Facilities

Noah Medical has unveiled a new 10,000 square foot research and training facility in Sunnyvale, California and a 15,000 square foot research and development (R&D) facility in San Carlos, California.

The company, founded by medical robotics entrepreneur Jian Zhang, will use these state-of-the-art facilities to pursue disruptive new medical robotics indications left unaddressed by current platforms.

“We envision a world in which next generation medical robots help diagnose disease and treat patients early to ensure minimal hospital stays and quick recoveries,” said Zhang, Noah Medical’s founder and CEO. “These facilities are just the latest step in our journey towards that reality and they will prove critical to the development and commercialization of our first platform.”

The new Sunnyvale facility will be used to complete testing of the Galaxy System™, Noah Medical’s first commercial robotic system, a robotic-assisted platform for minimally invasive peripheral lung navigation, ahead of a planned filing for FDA clearance later in 2022. The facility will also serve as the sales and customer training site as the company plans for commercialization.

The new San Carlos facility, less than a mile from Noah Medical’s headquarters in San Carlos, will be used to expand Noah’s R&D capabilities and engineering team to bolster investigational capabilities and new pipeline product development.

The Society for Advanced Bronchoscopy will host a webinar to discuss the medical robotics landscape in lung navigation on March 15, 2022. Led by the Cleveland Clinic’s Dr Joseph Cicenia, University of Chicago’s Dr Kyle Hogarth and CHI Memorial’s Dr Krish Bhadra, the event will highlight Noah Medical’s new robotics technology and its potential improvement on navigational capabilities and efficiency.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy